Clinical Trial Update: Effect of Inhaled Albuterol in Pulmonary Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating inhaled albuterol for pulmonary hypertension has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Albuterol (albuterol)

Snippet

Sponsor: University of Miami | Conditions: Pulmonary Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2021-08-30